CAS 114-07-8

Eritromicina

Descrição:

Eritromicina é um antibiótico macrolídeo que é usado principalmente para tratar infecções bacterianas. É derivado da bactéria Saccharopolyspora erythraea e é eficaz contra uma variedade de bactérias Gram-positivas e algumas Gram-negativas. A estrutura química de Eritromicina apresenta um grande anel de lactona, que é característico dos macrolídeos, juntamente com vários grupos de açúcar que contribuem para sua solubilidade e atividade biológica. Eritromicina atua inibindo a síntese de proteínas bacterianas, impedindo assim o crescimento e a reprodução das bactérias. É comumente usado no tratamento de infecções do trato respiratório, infecções de pele e certas infecções sexualmente transmissíveis. Eritromicina está disponível em várias formulações, incluindo comprimidos orais, pomadas tópicas e preparações intravenosas. Embora geralmente seja bem tolerado, pode causar efeitos colaterais como distúrbios gastrointestinais e pode interagir com outros medicamentos devido aos seus efeitos sobre as enzimas hepáticas. A resistência a Eritromicina foi observada em algumas cepas bacterianas, o que pode limitar sua eficácia em certas infecções.

Fórmula: C₃₇H₆₇NO₁₃

InChI: InChI=1/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21?,22-,23+,24+,25-,26+,28-,29?,30?,31+,32?,34?,35-,36-,37-/m1/s1

Chave InChI: InChIKey=ULGZDMOVFRHVEP-RWJQBGPGSA-N

SMILES: O([C@@H]1[C@@H](C)[C@H](O[C@H]2C[C@](OC)(C)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)O)[C@H]3[C@H](O)[C@@H](N(C)C)C[C@@H](C)O3

Sinónimos:

• (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
• (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name)
• (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
• (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
• (3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
• 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
• Abboticin
• Abomacetin
• Ak-Mycin
• Aknin
• Dotycin
• Drmysin
• E-Base
• E-mycin
• E.E.S
• EMU
• Emgel
• Ergel
• Eritocina
• Eritrex
• Eritrocina
• Eritromed
• Eritromicina
• Ermycin
• Erthrogran
• Ery Derm
• Ery-Ped
• Ery-Tab
• EryDerm
• Eryacne
• Eryc
• Erycen
• Erycette
• Erycin
• Erycinum
• Erygel
• Erymax
• Erytab
• Erythro
• Erythrocin
• Erythrogran
• Erythroguent
• Erythromast
• Erythromast 36
• Erythromid
• Erythromycin A
• Erythromycine
• Ilocap
• Ilosone
• Ilotycin
• Inderm
• L-alpha-Egg-phosphatidylcholine
• Nsc 55929
• Oxacyclotetradecane, erythromycin deriv.
• Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
• Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
• P.C.E.
• PCE
• Pantomicina
• Pediamycin
• Retcin
• Robimycin
• Statcin
• Staticin
• Stiemycin
• T-Stat
• Theramycin Z
• Torlamicina
• Torlamicna
• Vetwic
• Wintrocin
• Wyamycin-s
• [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
• [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
• Erythromycin
• ErMysin
• ERYTHROMYCIN STANDARD SOLUTION*
• ERYTHROMYCIN BASE
• ERYTHROMYCIN USP(CRM STANDARD)
• Abomacetin AK-Mycin, Aknin
• Erythromycin,Erythromycinum
• StreptoMyces erythreus
• ERYTHROMYCIN, PH EUR
• em
• ibo-hexopyranosyl)-oxy)-14-ethyl-7,12,13-tr///
• BRAND? volumetric flask BLAUBRAND? USP conformity certified
• (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione
• propiocine
• nosyl)-oxy)-6,11,12,13-tetrahydroxy-2,4,6,8///
• Radix Ophiopogonis P.E.
• ERYTHROMYCIN C USP(CRM STANDARD)
• ERYTHROMYCIN.BASERESEARCH GRADE
• ERYTHROMYCIN THICYANATE
• (-)-Erythromycin, Eur.Pharm.
• erythromycin,compdwithmonododecylsulfate,sodiumsalt
• ERYTHROMYCIN WHO(CRM STANDARD)
• ERYTHROMYCIN CELL CULTURE TESTED
• (3R,5R,6S,7R,8R,11R,13R,14R,15S,16R)-7-((2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-16-ethyl-8,14,15-trihydroxy-5-((2R,4S,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy)-3,6,8,11,13,15-hexamethyloxacyclohexadecane-2,12-dione
• ERYTHROMYCIN B USP(CRM STANDARD)
• pentadecanoicacid,3-((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyra
• ERYTHROMYCIN, BIOTECHNOLOGY PERFORMANCE
• sulfuricacid,monododecylester,sodiumsalt,compdwitherythromycin
• USP
• ERYTHROMYCIN MIXTURE A,B,C
• BRAND? USP BLAUBRAND? class AS graduated pipette
• ERYTHROMYCIN A EPE(CRM STANDARD)
• BRAND? USP BLAUBRAND? volumetric pipettes, one-mark
• BRAND? USP BLAUBRAND? class A measuring cylinder, tall form
• oxacyclotetradecane-2,10-dione,4-((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-r
• ERYTHROMYCIN 960 I.U./MG EPE(CRM STANDARD)
• BRAND? volumetric flask, USP, BLAUBRAND
• ERYTHROMYCIN PLANT CELL CULTURE TESTED
• Aknemycin
• ErythromycinAlkali
• ERYTHROMYCINUM
• Erythromycin (250 mg)
• ERYTHROMYCIN C*) EPE(CRM STANDARD)
• Erythromycin BasePhosphate & Salts
• ERYTHROMYCIN (90-95% ERYTHROMYCIN A)
• Bulb pipettes
• Erytromycin A
• Erithromycin
• Ilotycin, ErythroMycin
• BRAND? volumetric flask BLAUBRAND? USP 27 conformity certified
• ERYTHROMYCIN,POWDER,USP
• ERYTHROMYCIN C WHO(CRM STANDARD)
• (-)-Erythromycin,98%
• ERYTHROMYCIN, STREPTOMYCES ERYTHREUS
• knin
• ERYTHROMYCIN CELL CULTURE REAGENT
• Erythromycin (base and/or unspecified salts)
• ErythroMycin COS/CGMP
• nci-c55674
• erythromast36
• ERYTHROMYCIN A,B,C
• ERYTHROMYCIN 98%
• ERYTHROMYCIN USP
• erythromycinsodiumlaurylsulfate
• ERYTHROMYCIN 9-OXIME 90+% HPLC
• Erythromycin,E-Mycin, Erythrocin
• BRAND? volumetric flask BLAUBRAND? USP
• ERYTHROMYCIN RELATED COMPOUND NN-DEMETHYLERYTHROMYCIN A USP(CRM STANDARD)
• ERYTHROMYCIN B EPE(CRM STANDARD)
• Erythromycin (mixture of A,B,C)
• Erythromycin-Bp/Ep/Usp

Erythromycin

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Pureza: >98.0%(T)

Cor e Forma: White to Orange to Green powder to crystal

Peso molecular: 733.94

Ref: 3B-E0751

Erythromycin, Cell Culture Grade

CAS: 114-07-8

Erythromycin, 114-07-8, is a broad-spectrum macrolide antibiotic which inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Learn more.

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: Crystals or powder or crystalline powder, Translucent or white to pale yellow

Peso molecular: 733.94

Ref: 02-J62279

ERYTHROMYCIN FOR SYSTEM SUITABILITY CRS

CAS: 114-07-8

ERYTHROMYCIN FOR SYSTEM SUITABILITY CRS

Fórmula: C₃₇H₆₇NO₁₃

Peso molecular: 733.9268

Ref: 41-Y0001847

ERYTHROMYCIN FOR MICROBIOLOGICAL ASSAY CRS

CAS: 114-07-8

ERYTHROMYCIN FOR MICROBIOLOGICAL ASSAY CRS

Fórmula: C₃₇H₆₇NO₁₃

Peso molecular: 733.9268

Ref: 41-E1300000

ERYTHROMYCIN RS

CAS: 114-07-8

ERYTHROMYCIN RS

Fórmula: C₃₇H₆₇NO₁₃

Peso molecular: 733.9268

Ref: 41-ICRS0298

THIRD INTERNATIONAL STANDARD FOR ERYTHROMYCIN

CAS: 114-07-8

THIRD INTERNATIONAL STANDARD FOR ERYTHROMYCIN

Ref: 41-ISA_65774

Erythromycin

CAS: 114-07-8

Erythromycin

Fórmula: C₃₆H₆₅NO₁₃ / C₃₇H₆₇NO₁₂ / C₃₇H₆₇NO₁₃

Pureza: 0.8% / 0.2% / 92.3%

Cor e Forma: White

Peso molecular: 719.44559 / 717.46633 / 733.46124

Ref: 47-781

ERYTHROMYCIN A CRS

CAS: 114-07-8

ERYTHROMYCIN A CRS

Fórmula: C₃₇H₆₇NO₁₃

Peso molecular: 733.9268

Ref: 41-Y0001912

Erythromycin

CAS: 114-07-8

Erythromycin and its derivatives; salts thereof

Fórmula: C₃₇H₆₇NO₁₃ErythromycinA

Cor e Forma: White Light Yellow Powder

Peso molecular: 733.94 Erythromycin A

Ref: 45-1242000

[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Pureza: 95%

Cor e Forma: Solid

Peso molecular: 733.9268

Ref: IN-DA0039A1

Erythromycin

CAS: 114-07-8

Erythromycin (E-Mycin) is a Macrolide and Macrolide Antimicrobial. The physiologic effect of erythromycin is by means of Decreased Sebaceous Gland Activity.

Fórmula: C₃₇H₆₇NO₁₃

Pureza: 99.26% - 99.77%

Cor e Forma: Hydrated Crystals From Water Physical Description Fluffy Colorless Powder Or Fine White Powder (Ntp 1992)

Peso molecular: 733.93

Ref: TM-T1032

Erythromycin

CAS: 114-07-8

Erythromycin

Fórmula: C₃₇H₆₇NO₁₃

Pureza: Assay: 96.5% (erythromycin (Typical Value in Batch COA)

Cor e Forma: white powder

Peso molecular: 733.93g/mol

Ref: 54-BIE0122

Erythromycin

CAS: 114-07-8

Erythromycin

Pureza: ≥98%

Peso molecular: 733.93g/mol

Ref: 54-BUP18313

Erythromycin

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Pureza: Erythromycin A+B+C: 93.0 - 102.0%

Cor e Forma: White or pale yellow powder

Peso molecular: 733.93

Ref: 7W-GA1145

Erythromycin (Roxithromycin EP Impurity A)

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: White To Off-White Solid

Peso molecular: 733.94

Ref: 4Z-E-203

Erythromycin 1000 µg/mL in Acetonitrile

Produto Controlado

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: Single Solution

Peso molecular: 733.93

Ref: 04-A13203490AL-1000

Pharmaceuticals Mixture 326 200 µg/mL in Methanol

Produto Controlado

CAS: 103-90-2, 114-07-8, 298-46-4, 56296-78-7, 58-08-2, 723-46-6, 738-70-5, 93107-08-5

Cor e Forma: Mixture

Ref: 04-A50000326ME

Erythromycin (mixture of A,B,C)

Produto Controlado

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: Neat

Peso molecular: 733.93

Ref: 04-C13203490

Erythromycin (mixture of A,B,C) 100 µg/mL in Acetonitrile

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: Single Solution

Peso molecular: 733.93

Ref: 04-A13203490AL-100

GB 31660.1-2019 Macrolide Antibiotics Mixture 167 100 µg/mL in Methanol

Produto Controlado

CAS: 114-07-8, 1401-69-0, 16846-24-5, 2751-09-9, 69-23-8, 8025-81-8, 81103-11-9, 83905-01-5, 93952-07-9

Cor e Forma: Mixture

Ref: 04-A50000167ME

Erythromycin-d3

Produto Controlado

CAS: 114-07-8

Applications Isotope labelled Erythromycin (E649950), an antibiotic useful for the treatment of a number of bacterial infection, usually prescribed to patients with allergy to penicillin.
References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979),

Fórmula: C₃₇H₆₄D₃NO₁₃

Cor e Forma: Neat

Peso molecular: 736.96

Ref: TR-E649954

Erythromycin

CAS: 114-07-8

Applications Erythromycin is an antibiotic.This compound is a contaminant of emerging concern (CECs).
References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979),

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: White

Peso molecular: 733.93

Ref: TR-E649950

Erythromycin

CAS: 114-07-8

A broad-spectrum antibiotic of macrolide class, which targets 50S ribosomal subunit and inhibits protein synthesis. Erythromycin is widely used in molecular biology and biotechnology as a selection marker. Erythromycin is also an agonist of the motilin receptor, and it has prokinetic activity on the gut.

Fórmula: C₃₇H₆₇NO₁₃

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 733.93 g/mol

Ref: 3D-AE22796

Erythromycin for tissue culture

CAS: 114-07-8

Fórmula: C₃₇H₆₇NO₁₃

Cor e Forma: White to off - white, Hygroscopic powder, Clear, Colourless

Peso molecular: 733.93

Ref: SR-48535

Erythromycin, Antibiotic for Culture Media Use Only

CAS: 114-07-8

Erythromycin, Antibiotic for Culture Media Use Only, is a macrolide antibiotic derived from the bacterium *Saccharopolyspora erythraea*. It functions by inhibiting protein synthesis, specifically targeting the 50S ribosomal subunit in susceptible bacteria. This action results in the prevention of peptide chain elongation, effectively halting bacterial growth and proliferation.

Fórmula: C₃₇H₆₇NO₁₃

Pureza: Min. 93.0 Area-%

Peso molecular: 733.93 g/mol

Ref: 3D-E-3250

Erythromycin A

CAS: 114-07-8

Erythromycin A

Fórmula: C₃₇H₆₇NO₁₃

Pureza: 96.7%

Cor e Forma: White

Peso molecular: 733.46124

Ref: 47-794